Identification of multidrug resistance‐associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine

No abstract is available for this paper.

• Publication year

  2004

• Venue

  BJU International

• Publication date

  2004-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1464-410X.2004.04847.xPMID 15180633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii

  2007cited by this paper
• Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man

  2005cited by this paper
• Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer.

  2001cited by this paper
• A family of drug transporters: the multidrug resistance-associated proteins.

  2000cited by this paper
• Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.

  1999cited by this paper
• Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins.

  1999cited by this paper
• Structural, mechanistic and clinical aspects of MRP1.

  1999cited by this paper
• Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells.

  1998cited by this paper
• The expression of drug resistance gene products during the progression of human prostate cancer.

  1998cited by this paper
• Selection for drug resistance results in resistance to Fas-mediated apoptosis.

  1997cited by this paper
• Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.

  1996cited by this paper
• Reconstitution of ATP-dependent Leukotriene C4 Transport by Co-expression of Both Half-molecules of Human Multidrug Resistance Protein in Insect Cells*

  1996cited by this paper
• Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C and Chemotherapeutic Agents in Membrane Vesicles

  1996cited by this paper
• Cell biological mechanisms of multidrug resistance in tumors.

  1994cited by this paper
• Cytotoxic chemotherapy for advanced hormone‐resistant prostate cancer

  1993cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist.

  1990cited by this paper
• Glutathione S-transferases and drug resistance.

  1990cited by this paper
• Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation.

  1989cited by this paper
• Role of the glutathione redox cycle in acquired and de novo multidrug resistance.

  1988cited by this paper
• Application of the MTT assay to human prostate cancer cell lines in vitro: Establishment of test conditions and assessment of hormone‐stimulated growth and drug‐induced cytostatic and cytotoxic effects

  1988cited by this paper
• Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.

  1987cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• Isolation of a human prostate carcinoma cell line (DU 145)

  1978cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Reactive oxygen species in cancer: Mechanistic insights and therapeutic innovations

  2025cites this paper
• Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies.

  2023cites this paper
• Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma

  2023cites this paper
• Cysteinyl Leukotriene Pathway and Cancer

  2021cites this paper
• Efflux transporters in anti-cancer drug resistance: Molecular and functional identification and characterization of multidrug resistance proteins (MRPs/ABCCs)

  2020cites this paper
• Etoposide Loaded SPION‐PNIPAM Nanoparticles Improve the in vitro Therapeutic Outcome on Metastatic Prostate Cancer Cells via Enhanced Apoptosis

  2020cites this paper
• Mitochondria-Targeting Polydopamine Nanoparticles To Deliver Doxorubicin for Overcoming Drug Resistance.

  2017cites this paper
• Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4)

  2016cites this paper
• Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

  2014cites this paper
• 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.

  2014cites this paper
• Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

  2012cites this paper
• Drug Design, Biological Activity, and Metabolic Consequences of Cytotoxic Platinum Compounds: Utilizing Fluorescent Tagging to Understand Drug Action and Metabolism

  2011cites this paper
• Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism.

  2011cites this paper
• Targeting drug transporters - combining in silico and in vitro approaches to predict in vivo.

  2010cites this paper
• Insulin in endometrial carcinoma chemotherapy: A beneficial addition and not a problem

  2010cites this paper
• Antioxidant-Prooxidant Properties of a New Organoselenium Compound Library

  2010cites this paper
• Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth

  2010cites this paper
• Insulin in endometrial carcinoma chemotherapy: A beneficial addition and not a problem

  2010cites this paper
• Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs

  2009cites this paper
• Liposomal gemcitabine (GemLip)—efficient drug against hormone‐refractory Du145 and PC‐3 prostate cancer xenografts

  2009cites this paper
• Synthesis and Pharmacological Screening of Several Aroyl and Heteroaroyl Selenylacetic Acid Derivatives as Cytotoxic and Antiproliferative Agents

  2009cites this paper
• Drug Transporter Pharmacophores

  2009cites this paper
• Modifikation der Chemosensitivität der humanen Prostatakarzinomzelllinie 22Rv1 unter dem Einfluss ionisierender Strahlung und Chemoselektion

  2009cites this paper
• Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

  2008cites this paper
• Eicosanoids and Resistance of Cancer Cells to Chemotherapeutic Agents

  2008cites this paper
• Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness.

  2007cites this paper
• Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells.

  2007cites this paper
• Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.

  2007cites this paper
• Chinese Herbs of Shenghe Powder Reverse Multidrug Resistance of Gastric Carcinoma SGC-7901

  2007cites this paper
• Pharmacophore-based discovery of ligands for drug transporters.

  2006cites this paper
• Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention.

  2006cites this paper
• The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.

  2006cites this paper
• Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance

  2006cites this paper